Gilead Prices Coronavirus Drug Remdesivir at $2,340 for Rich Countries
Published
Published
Gilead Sciences said it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting..
Just days after getting conditional approval for its coronavirus drug remdesivir in Europe, Gilead has announced pricing for the..